Full Text View
Tabular View
No Study Results Posted
Related Studies
Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients (Certi-CMV)
This study is currently recruiting participants.
Verified August 2012 by Medical University of Vienna
Study NCT00828503   Information provided by Medical University of Vienna

First Received on January 23, 2009.   Last Updated on August 30, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial